FDA Advisers Urge Approval of Romosozumab for Osteoporosis FDA Advisers Urge Approval of Romosozumab for Osteoporosis

The risk for cardiac events, though not well defined, should not hold up marketing, said the FDA panel members.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news